Time: 11:53

UWA drug offers…

A new drug for the treatment of Duchenne Muscular Dystrophy originally developed at The University of Western Australia has been approved by the US FDA. UWA’s Deputy Vice-Chancellor Research Professor Robyn Owens said the drug Eteplirsen offered new hope for sufferers…

Read More...
UWA drug offers new hope to young…
A new drug for the treatment of Duchenne Muscular Dystrophy originally developed at The University…

AusBiotech nominates for…

Following a request from the Department of Health, AusBiotech has this week provided nominees for appointment to one position on the reconstituted Prostheses List Advisory Committee (PLAC). The Minister for Health and Ageing, the Hon Sussan Ley, announced reform to…

Read More...
AusBiotech nominates for Prostheses List advisory
Following a request from the Department of Health, AusBiotech has this week provided nominees for…

Greens go hard…

The Greens recently appointed spokesperson for trade, Senator Sarah Hanson-Young, has set a ‘dramatic’ tone for the portfolio, describing the 12-country Trans Pacific Partnership Agreement as a “disastrous” deal that will drive up the cost of cancer drugs. “This deal will…

Read More...
Greens go hard against TPP
The Greens recently appointed spokesperson for trade, Senator Sarah Hanson-Young, has set a ‘dramatic’ tone for…

Latest News

22 September 2016Latest News

UWA drug offers new hope to young muscular dystrophy sufferers

A new drug for the treatment of Duchenne Muscular Dystrophy originally developed at The University of Western Australia has been…

22 September 2016Latest News

AusBiotech nominates for Prostheses List advisory

Following a request from the Department of Health, AusBiotech has…

22 September 2016Latest News

Greens go hard against TPP

The Greens recently appointed spokesperson for trade, Senator Sarah Hanson-Young, has…

22 September 2016Company News

Bayer could drop Monsanto name

Bayer could integrate the assets of Monsanto into its own crop science division and drop the controversial company’s name altogether,…

22 September 2016Latest News

Proteomics announces half million dollar R&D tax…

Innovative biomarker research conducted by Proteomics International (ASX:PIQ) has been…

20 September 2016Latest News

MTAA chief executive resigns

MTAA chief executive Susi Tegen has resigned for health reasons.…

20 September 2016Latest News

Senate passes R&D tax cut

A hit for medical research in Australia with the Senate…

20 September 2016Latest News

Hacking their way to healthcare solutions

A team developing a wearable device to improve patient compliance and treatment outcomes for knee rehabilitation after a reconstruction has won…

20 September 2016Latest News

DibbsBarker to open Melbourne office

Leading law firm and AusBiotech member DibbsBarker is expanding with…